Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Acquired dermal melanocytosis induced by psoralen plus ultraviolet A therapy.

Nagase K, Hirashima N, Koba S, Inoue T, Misago N, Narisawa Y.

Acta Derm Venereol. 2012 Nov;92(6):691-2. doi: 10.2340/00015555-1282. No abstract available.

2.

Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.

McKenna KE.

Photodermatol Photoimmunol Photomed. 2004 Dec;20(6):289-96. Review.

PMID:
15533236
4.

Mycosis fungoides with depigmentation secondary to treatment.

Firoz B, Kovich OI, Latkowski JA.

Dermatol Online J. 2007 Jan 27;13(1):18.

PMID:
17511951
6.

Evaluation of psoralen-UV-B (311-nm) bath phototoxicity.

Neumann NJ, Schlotmann K, Ruzicka T, Lehmann P.

Arch Dermatol. 1998 Oct;134(10):1299-300. No abstract available.

PMID:
9801698
7.

Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV.

Khurshid K, Haroon TS, Hussain I, Pal SS, Jahangir M, Zaman T.

Int J Dermatol. 2000 Nov;39(11):865-7.

PMID:
11123453
8.

Tanning caused by psoralen-photochemotherpy in Indian skin.

Gupta S, Ajith C.

Indian J Dermatol Venereol Leprol. 2009 Jan-Feb;75(1):76-7. No abstract available.

9.

Benzylamide derivative compound attenuates the ultraviolet B-induced hyperpigmentation in the brownish guinea pig skin.

Choi SY, Kim S, Hwang JS, Lee BG, Kim H, Kim SY.

Biochem Pharmacol. 2004 Feb 15;67(4):707-15.

PMID:
14757170
10.

Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.

Sivanesan SP, Gattu S, Hong J, Chavez-Frazier A, Bandow GD, Malick F, Kricorian G, Koo J.

J Am Acad Dermatol. 2009 Nov;61(5):793-8. doi: 10.1016/j.jaad.2009.04.053. Epub 2009 Sep 18.

PMID:
19766350
11.

Severe burns following phototherapy with PUVA for vetiligo: a preventable complication that still happening.

Suliman MT, Abdolmoneim M.

Burns. 2005 Dec;31(8):1063. Epub 2005 Nov 9. No abstract available.

PMID:
16288964
12.

Cutaneous pigmented melanocytic tumor in a mouse treated with psoralen plus ultraviolet A radiation.

Alcalay J, Bucana C, Kripke ML.

Photodermatol Photoimmunol Photomed. 1990 Feb;7(1):28-31.

PMID:
2371167
13.

Burns caused by accidental overdose of photochemotherapy (PUVA).

Herr H, Cho HJ, Yu S.

Burns. 2007 May;33(3):372-5. Epub 2007 Jan 10.

PMID:
17218059
14.

Acquired dermal melanocytosis of the hand at the site of treated psoriasis.

Kelley BP, Doherty SD, Calame A, Hsu S.

Dermatol Online J. 2009 Dec 15;15(12):2.

15.

Psoralens used for cosmetic sun tanning: an unusual cause of extensive burn injury.

Nettelblad H, Vahlqvist C, Krysander L, Sjöberg F.

Burns. 1996 Dec;22(8):633-5.

PMID:
8982544
16.

Concentration-dependent phototoxicity in trimethylpsoralen bath psoralen ultraviolet A.

Snellman E, Rantanen T.

Br J Dermatol. 2001 Mar;144(3):490-4.

PMID:
11260004
17.

Patchy speckled bath PUVA pigmentation.

Poskitt BL, Wilkinson JD, Wojnarowska FT, Chia YC.

J R Soc Med. 1993 Nov;86(11):665-6. No abstract available.

18.

Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.

Anbar TS, El-Sawy AE, Attia SK, Barakat MT, Moftah NH, El-Ammawy TS, Abdel-Rahman AT, El-Tonsy MH.

Photodermatol Photoimmunol Photomed. 2012 Feb;28(1):17-25. doi: 10.1111/j.1600-0781.2011.00631.x.

PMID:
22211999
19.

Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation.

Scott G, Jacobs S, Leopardi S, Anthony FA, Learn D, Malaviya R, Pentland A.

Exp Cell Res. 2005 Apr 1;304(2):407-16. Epub 2004 Dec 15.

PMID:
15748887
20.

Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn.

Tomita Y, Maeda K, Tagami H.

Dermatologica. 1989;179 Suppl 1:49-53.

PMID:
2550287

Supplemental Content

Support Center